← Leaderboards
Robin L Anderson
Peter Maccallum Cancer Centre
$578,744
Attributed
$578,744
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$578,744 · 2
By mechanism
R01$578,744 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Complementary Dna”
- Richard A Gibbs · Baylor College Of Medicine$69,931,354
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$51,638,485
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$48,949,532
- James E Crowe · Vanderbilt University Medical Center$38,056,004
- Jay D Keasling · University Of California-Berkeley$37,433,392
Research focus
Complementary DnaMicroarray TechnologyNeoplasm /Cancer GeneticsNeoplasm /Cancer InvasivenessGenetic MarkersNorthern BlottingsBreast NeoplasmsPolymerase Chain ReactionHuman TissueImmunocytochemistryScid MouseBone NeoplasmsIn Situ HybridizationLung NeoplasmsMetastasisLymph Node NeoplasmNeoplastic CellNucleic Acid SequenceProtein Structure FunctionRadiation CarcinogenStress ProteinsTissue /Cell CultureTransposon /Insertion ElementApoptosis
Grant awards (5)
Genes important in breast cancer metastasis$135,000
R01 · FY2003 · CA
Genes important in breast cancer metastasis$135,000
R01 · FY2002 · CA
Genes important in breast cancer metastasis$135,000
R01 · FY2001 · CA
APOPTOSIS--ROLE OF HSP72 AND NOVEL DEATH ANTAGONISTS$88,217
R01 · FY2001 · CA
APOPTOSIS--ROLE OF HSP72 AND NOVEL DEATH ANTAGONISTS$85,527
R01 · FY2000 · CA